Loading organizations...
Newlin Investment Company operates as a private equity and venture capital firm, specializing in long-term investments across growth and value opportunities. The company actively supports enterprises within diverse sectors, including technology, industrial, and retail markets. Its core approach involves providing capital and strategic guidance to foster expansion and sustainable development within its portfolio.
The firm was established in 2007 by William R. Newlin, who serves as its Chairman. Newlin founded the company with the intent to identify and nurture promising businesses through dedicated investment. Building upon an extensive professional background, his vision was to create an investment vehicle capable of contributing to the long-term success of growing enterprises.
Newlin Investment Company primarily serves emerging and established businesses seeking capital for expansion and strategic partnership. The firm’s mission is to catalyze the potential of its portfolio companies, driving their evolution and market impact. It aims for enduring value creation by committing to these ventures long term, envisioning substantial economic and sectoral contributions.
Newlin Investment Company has 1 tracked investment across 1 company. The latest tracked deal is $3.0M Series A in Carmell Therapeutics in April 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 15, 2011 | Carmell Therapeutics | $3.0M Series A | Harbor Light Capital | Ariel Southeast Angel Partners, BlueTree Allied Angels, Innovation Works, Pittsburgh Life Sciences Greenhouse |